{"@context":{"@vocab":"https://schema.org/"},"@type":"Drug","@id":"https://api.morvs.ai/drug-product/43386-090#drug","name":"GAVILYTE G TM","alternateName":"polyethylene glycol-3350 and Electrolytes","identifier":[{"@type":"PropertyValue","propertyID":"FDA National Drug Code (NDC)","value":"43386-090"},{"@type":"PropertyValue","propertyID":"FDA application number","value":"ANDA090231"},{"@type":"PropertyValue","propertyID":"UNII","value":"G2M7P15E5P|660YQ98I10|8MDF5V39QO|451W47IQ8X|36KCS0R750"},{"@type":"PropertyValue","propertyID":"SPL Set ID","value":"3978822b-6473-4072-9f80-20ceb9bea355"}],"activeIngredient":"POLYETHYLENE GLYCOL 3350, POTASSIUM CHLORIDE, SODIUM BICARBONATE, SODIUM CHLORIDE, SODIUM SULFATE ANHYDROUS","administrationRoute":["ORAL"],"dosageForm":"POWDER, FOR SOLUTION","manufacturer":{"@type":"Organization","name":"Lupin Pharmaceuticals,Inc."},"drugClass":[],"isAvailableGenerically":true,"legalStatus":"HUMAN PRESCRIPTION DRUG","sameAs":["https://api.morvs.ai/drug-approval/ANDA090231","https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=3978822b-6473-4072-9f80-20ceb9bea355","https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=43386-090"],"isAccessibleForFree":true,"license":"https://creativecommons.org/publicdomain/zero/1.0/","_source":{"data_provider":"AI Analytics","brand_name":"MORVS","brand_url":"https://morvs.ai/","data_provider_url":"https://api.morvs.ai","license":"https://creativecommons.org/publicdomain/zero/1.0/","primary_source":"https://open.fda.gov/apis/drug/ndc/","generated_at":"2026-11-01T22:15:08.801Z"}}